CIM
AGN

Contravisory Investment Management’s Allergan plc AGN Stock Holding History

Contravisory Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-21,058
Closed -$2.81M – 354
2018
Q4 		$2.81M Buy
+21,058
New +$3.45M 1.22% 41
2018
Q1 		– Sell
-31
Closed -$5K – 491
2017
Q4 		$5K Sell
31
-56
-64% -$10K ﹤0.01% 292
2017
Q3 		$18K Buy
+87
New +$20.2K 0.01% 236
2016
Q2 		– Sell
-7
Closed -$2K – 236
2016
Q1 		$2K Hold
7
– – ﹤0.01% 192
2015
Q4 		$2K Buy
+7
New +$2.08K ﹤0.01% 198

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Contravisory Investment Management's AGN Position: Q1 2019 in Review

Contravisory Investment Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 21,058 shares — an estimated $2.81M sold.

Contravisory Investment Management first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $2.81M in Q4 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Contravisory Investment Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Contravisory Investment Management sold 21,058 Allergan plc shares in Q1 2019, an estimated $2.81M.
  • Contravisory Investment Management first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • Contravisory Investment Management's Allergan plc position peaked at $2.81M in Q4 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Contravisory Investment Management's 13F filing for Q1 2019, filed 8 Apr 2019.